Scientific Reports (Aug 2022)
Retraction Note: Selective Priming of Tumor Blood Vessels by Radiation Therapy Enhances Nanodrug Delivery
- Sijumon Kunjachan,
- Shady Kotb,
- Robert Pola,
- Michal Pechar,
- Rajiv Kumar,
- Bijay Singh,
- Felix Gremse,
- Reza Taleeli,
- Florian Trichard,
- Vincent Motto-Ros,
- Lucie Sancey,
- Alexandre Detappe,
- Sayeda Yasmin-Karim,
- Andrea Protti,
- Ilanchezhian Shanmugam,
- Thomas Ireland,
- Tomas Etrych,
- Srinivas Sridhar,
- Olivier Tillement,
- Mike Makrigiorgos,
- Ross I. Berbeco
Affiliations
- Sijumon Kunjachan
- Department of Radiation Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School
- Shady Kotb
- Department of Radiation Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School
- Robert Pola
- Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic
- Michal Pechar
- Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic
- Rajiv Kumar
- Department of Radiation Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School
- Bijay Singh
- Department of Physics, Nanomedicine Science and Technology Center, Northeastern University
- Felix Gremse
- Experimental Molecular Imaging, University Hospital and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University
- Reza Taleeli
- Division of Medical Physics & Engineering, University of Texas Southwestern Medical Center
- Florian Trichard
- Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon 1, CNRS
- Vincent Motto-Ros
- Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon 1, CNRS
- Lucie Sancey
- Institute for Advanced Biosciences, UMR 5309 Joint Research Center, UGA/INSERM U1209, CNRS
- Alexandre Detappe
- Department of Radiation Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School
- Sayeda Yasmin-Karim
- Department of Radiation Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School
- Andrea Protti
- Lurie Family Imaging Center, Department of Radiology, Dana-Farber Cancer Institute and Harvard Medical School
- Ilanchezhian Shanmugam
- Department of Physics, Nanomedicine Science and Technology Center, Northeastern University
- Thomas Ireland
- Department of Earth and Environmental Sciences, LA-ICP-MS and ICP-ES Laboratories, Boston University
- Tomas Etrych
- Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic
- Srinivas Sridhar
- Department of Radiation Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School
- Olivier Tillement
- Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon 1, CNRS
- Mike Makrigiorgos
- Department of Radiation Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School
- Ross I. Berbeco
- Department of Radiation Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School
- DOI
- https://doi.org/10.1038/s41598-022-17483-7
- Journal volume & issue
-
Vol. 12,
no. 1
pp. 1 – 1
Abstract
No abstracts available.